Last reviewed · How we verify
Remi 0.3
At a glance
| Generic name | Remi 0.3 |
|---|---|
| Also known as | remifentanil, Ultiva, Glaxo Wellcome, Marly-le-Roi, |
| Sponsor | Dokuz Eylul University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy (PHASE4)
- Remifentanil on Hemodynamic Response to Anesthesia Induction (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |